Home > Boards > US Listed > Biotechs > Geron Corp. (GERN)

Geron halted the spinal injury program due to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Liquid_Bull Member Profile
 
Followed By 3
Posts 790
Boards Moderated 0
Alias Born 01/10/10
160x600 placeholder
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference Business Wire - 1/21/2022 7:30:00 AM
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 1/20/2022 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2022 8:31:20 AM
Geron to Present at the H.C. Wainwright BioConnect Conference Business Wire - 1/4/2022 5:01:00 PM
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 12/16/2021 4:30:00 PM
Geron Reports Presentations at American Society of Hematology Annual Meeting Business Wire - 12/14/2021 4:30:00 PM
Geron appoints chief business officer Seeking Alpha - 12/2/2021 9:13:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 7:51:20 AM
Geron Announces Appointment of Chief Business Officer Business Wire - 12/2/2021 7:30:00 AM
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 11/18/2021 4:30:00 PM
Geron to Present at the Stifel 2021 Virtual Healthcare Conference Business Wire - 11/12/2021 7:30:00 AM
Geron slips despite quarterly EPS, revenue beat Seeking Alpha - 11/10/2021 2:01:37 PM
Geron EPS beats by $0.01, beats on revenue Seeking Alpha - 11/10/2021 8:46:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2021 6:04:03 AM
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting Business Wire - 11/4/2021 9:12:00 AM
Baird initiates Geron with an outperform on outlook for lead candidate imetelstat Seeking Alpha - 11/2/2021 8:12:34 AM
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat Business Wire - 10/25/2021 4:30:00 PM
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 10/21/2021 4:30:00 PM
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes Business Wire - 10/18/2021 7:30:00 AM
Geron to Host a Virtual Investor Event in November Business Wire - 10/15/2021 4:05:00 PM
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology Business Wire - 10/11/2021 4:30:00 PM
Understanding Changes in Geron’s Risk Factors TipRanks - 10/5/2021 6:10:08 AM
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 9/16/2021 4:30:00 PM
Geron Announces September Investor Conference Presentation Webcasts Business Wire - 9/1/2021 4:30:00 PM
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire - 8/19/2021 4:30:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences